Dietmar Rohleder becomes CFO of Haupt Pharma AG

Rohleder takes over as Schwella focuses on production in Berlin

Dietmar Rohleder has been appointed chief financial officer of Haupt Pharma AG by the Supervisory Board with immediate effect.

Rohleder takes over responsibility for the areas of finance, accounting and controlling from the previous CFO, Norbert Schwella.
 As a member of the extended Board committee, Schwella will retain responsibilities for purchasing and IT. In addition, he will be focussing on his role as md of the Group's Berlin production company. Under his leadership, this company has undergone a radical reorganisation over the past two years and today it is Haupt Pharma’s most important site for the production of solid drugs in the OTC segment.

Rohleder has 19 years of working in a wide range of roles in Deutsche Bank's loans and corporate banking business. In 2005 he was appointed to the Board of what is now INVITA AG, where he has been responsible for managing and controlling the holding company ever since.

By appointing Mr Rohleder as the CFO to its holding company Haupt Pharma AG, INVITA AG is demonstrating its support for the strategic path the company is following with the aim of becoming the leading contract manufacturer and developer in Europe.

You may also like

Finance

Merck to acquire cancer biotech Terns Pharmaceuticals for $6.7bn

The purchase is the third multibillion-dollar acquisition for the pharma giant in the past year, as it moves to bolster its cancer portfolio ahead of its best-selling drug Keytruda losing patent protection in 2028
Marketing

Indena to highlight expanded HPAPI, ADC and peptide drug conjugate capabilities at DCAT Week 2026

Italian CDMO Indena will showcase its high-potency API manufacturing expertise and growing oncology-focused capabilities at DCAT Week in New York, including ten commercial HPAPIs in production and advancing work in antibody-drug and peptide drug conjugates
Manufacturing

Wilmington PharmaTech invests $50m into US small-molecule API manufacturing plant

The CRDMO will more than double the capacity in its current API reactor in Delaware, positioning itself to meet growing demand for US-based manufacturing
Manufacturing

L.B. Bohle at Interphex 2026

Continuous manufacturing and tablet processing technologies
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Sealing confidence: how Torbay Pharma ensures sterile precision from fill to finish

Torbay Pharma combines reliable crimp capping and precision pump technologies to maintain the sterile integrity, accurate dosing and uninterrupted supply of critical injectable medicines
Manufacturing

New agitator platform from Alfa Laval: A milestone breakthrough in effortless mixing in hygienic production

Delivering massive energy savings, easy maintenance – and prepared for industrial connectivity, the new EnSaLineTM agitators from Alfa Laval set a new standard for exceptional agitator performance
Manufacturing

Reliable detection for high-temperature processes

ifm has launched the LMH point level sensor, a robust solution engineered for reliable medium detection in demanding industrial environments
Subscribe now